Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variants of IL6, IL10, FCN2, RNASE3, IL12B and IL17B loci are associated with Schistosoma mansoni worm burden in the Albert Nile region of Uganda.
Nyangiri OA, Mulindwa J, Namulondo J, Kitibwa A, Nassuuna J, Elliott A, Kimuda MP, Boobo A, Nerima B, Adriko M, Dunton NJ, Madhan GK, Kristiansen M, Casacuberta-Partal M, Noyes H, Matovu E; TrypanoGEN+ Research group of the H3Africa consortium. Nyangiri OA, et al. Among authors: elliott a. PLoS Negl Trop Dis. 2023 Nov 30;17(11):e0011796. doi: 10.1371/journal.pntd.0011796. eCollection 2023 Nov. PLoS Negl Trop Dis. 2023. PMID: 38033168 Free PMC article.
Capacity for science in sub-Saharan Africa.
Elliott A, Nerima B, Bagaya B, Kambugu A, Joloba M, Cose S, Pantaleo G, Yazdanbakhsh M, Mabey D, Dunne D, Moffett A, Rwakishaya EK, Kaleebu P, Mbidde EK. Elliott A, et al. Lancet. 2015 Jun 20;385(9986):2435-7. doi: 10.1016/S0140-6736(15)61111-4. Lancet. 2015. PMID: 26122054 No abstract available.
Schistosoma mansoni-specific immune responses and allergy in Uganda.
Nkurunungi G, Kabagenyi J, Nampijja M, Sanya RE, Walusimbi B, Nassuuna J, Webb EL, Elliott AM; LaVIISWA study team. Nkurunungi G, et al. Among authors: elliott am. Parasite Immunol. 2018 Jan;40(1):e12506. doi: 10.1111/pim.12506. Epub 2017 Dec 15. Parasite Immunol. 2018. PMID: 29171863 Free PMC article.
The Impact of Intensive Versus Standard Anthelminthic Treatment on Allergy-related Outcomes, Helminth Infection Intensity, and Helminth-related Morbidity in Lake Victoria Fishing Communities, Uganda: Results From the LaVIISWA Cluster-randomized Trial.
Sanya RE, Nkurunungi G, Hoek Spaans R, Nampijja M, O'Hara G, Kizindo R, Oduru G, Kabuubi Nakawungu P, Niwagaba E, Abayo E, Kabagenyi J, Zziwa C, Tumusiime J, Nakazibwe E, Kaweesa J, Muwonge Kakooza F, Akello M, Lubyayi L, Verweij J, Nash S, van Ree R, Mpairwe H, Tukahebwa E, Webb EL, Elliott AM; LaVIISWA Trial Team. Sanya RE, et al. Clin Infect Dis. 2019 May 2;68(10):1665-1674. doi: 10.1093/cid/ciy761. Clin Infect Dis. 2019. PMID: 30202872 Free PMC article. Clinical Trial.
Does Intensive Treatment Select for Praziquantel Resistance in High-Transmission Settings? Parasitological Trends and Treatment Efficacy Within a Cluster-Randomized Trial.
Tushabe JV, Lubyayi L, Sserubanja J, Kabuubi P, Abayo E, Kiwanuka S, Nassuuna J, Kaweesa J, Corstjens P, van Dam G, Sanya RE, Ssenyonga W, Tukahebwa EM, Kabatereine NB, Elliott AM, Webb EL; LaVIISWA trial team. Tushabe JV, et al. Open Forum Infect Dis. 2020 Mar 12;7(4):ofaa091. doi: 10.1093/ofid/ofaa091. eCollection 2020 Apr. Open Forum Infect Dis. 2020. PMID: 32296727 Free PMC article.
Candidate gene family-based and case-control studies of susceptibility to high Schistosoma mansoni worm burden in African children: a protocol.
Nyangiri OA, Edwige SA, Koffi M, Mewamba E, Simo G, Namulondo J, Mulindwa J, Nassuuna J, Elliott A, Karume K, Mumba D, Corstjens PLAM, Casacuberta-Partal M, van Dam GJ, Bucheton B, Noyes H, Matovu E; TrypanoGEN+ Research Group of the H3Africa Consortium. Nyangiri OA, et al. Among authors: elliott a. AAS Open Res. 2021 Dec 15;4:36. doi: 10.12688/aasopenres.13203.2. eCollection 2021. AAS Open Res. 2021. PMID: 35252746 Free PMC article.
Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.
Muir R, Metcalf T, Fourati S, Bartsch Y, Kyosiimire-Lugemwa J, Canderan G, Alter G, Muyanja E, Okech B, Namatovu T, Namara I, Namuniina A, Ssetaala A, Mpendo J, Nanvubya A, Kitandwe PK, Bagaya BS, Kiwanuka N, Nassuna J, Biribawa VM, Elliott AM, de Dood CJ, Senyonga W, Balungi P, Kaleebu P, Mayanja Y, Odongo M, Connors J, Fast P, Price MA, Corstjens PLAM, van Dam GJ, Kamali A, Sekaly RP, Haddad EK. Muir R, et al. Among authors: elliott am. PLoS Negl Trop Dis. 2023 Jul 5;17(7):e0011089. doi: 10.1371/journal.pntd.0011089. eCollection 2023 Jul. PLoS Negl Trop Dis. 2023. PMID: 37406029 Free PMC article.
Transcriptome analysis of peripheral blood of Schistosoma mansoni infected children from the Albert Nile region in Uganda reveals genes implicated in fibrosis pathology.
Namulondo J, Nyangiri OA, Kimuda MP, Nambala P, Nassuuna J, Egesa M, Nerima B, Biryomumaisho S, Mugasa CM, Nabukenya I, Kato D, Elliott A, Noyes H, Tweyongyere R, Matovu E, Mulindwa J; TrypanoGEN+ research group of the H3Africa consortium. Namulondo J, et al. Among authors: elliott a. PLoS Negl Trop Dis. 2023 Nov 15;17(11):e0011455. doi: 10.1371/journal.pntd.0011455. eCollection 2023 Nov. PLoS Negl Trop Dis. 2023. PMID: 37967122 Free PMC article.
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial.
Nkurunungi G, Nassuuna J, Natukunda A, Zirimenya L, Walusimbi B, Zziwa C, Ninsiima C, Kabagenyi J, Kabuubi PN, van Dam GJ, Corstjens PLAM, Kayiwa J, Kizza M, Mutebe A, Nakazibwe E, Akello FA, Sewankambo M, Kiwanuka S, Cose S, Wajja A, Kaleebu P, Webb EL, Elliott AM; POPVAC trial team. Nkurunungi G, et al. Among authors: elliott am. Lancet Glob Health. 2024 Nov;12(11):e1826-e1837. doi: 10.1016/S2214-109X(24)00280-8. Lancet Glob Health. 2024. PMID: 39424571 Free PMC article. Clinical Trial.
1,963 results